background image

Multiple Myeloma Clinical Trials

Find clinical trials for multiple myeloma. Search for multiple myeloma clinical trials in different cities and states across the United States.

Filter
1
Active & ResponsiveNew

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

for
Multiple Sclerosis,
Location: 1 recruiting location
Sponsor: Northwestern University

Sex: All

Age: 18 - 70

Code: NCT07225361

Recruiting
Active & ResponsiveNew

A Superiority Trial of Radiofrequency Ablation for Low Back Pain

for
Chronic Low Back Pain (CLBP)
Location: 2 recruiting locations
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07222462

Recruiting
Active & ResponsiveNew

Study of Healthy Aging and Physical Function With Elamipretide

for
Aging, Healthy
Location: 1 recruiting location
Sponsor: David Marcinek

Sex: All

Age: 65 - 70+

Code: NCT07275424

Phase2, Recruiting
Active & Responsive

64Cu-LLP2A for Imaging Hematologic Malignancies

for
Multiple Myeloma, Low-Grade Lymphoma, Follicular Lymphoma,
Location: 1 recruiting location
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06636175

Early_phase1, Recruiting
Active & Responsive

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: 15 recruiting locations
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT05722418

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: 2 recruiting locations
Sponsor: Oncotherapeutics

Sex: All

Age: 0+

Code: NCT06115135

Phase2, Recruiting
Active & Responsive

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

for
Multiple Myeloma
Location: 4 recruiting locations
Sponsor: Canadian Myeloma Research Group

Sex: All

Age: 65+

Code: NCT05272826

Phase2, Recruiting
Active & Responsive

HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM

for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: 1 recruiting location
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06822972

Phase2, Recruiting
Active & Responsive

National Cancer Institute "Cancer Moonshot Biobank"

for
Acute Myeloid Leukemia,
Location: 109 recruiting locations
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 13+

Code: NCT04314401

Recruiting
Active & Responsive

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

for
Secondary Progressive Multiple Sclerosis
Location: 7 recruiting locations
Sponsor: Tiziana Life Sciences LTD

Sex: All

Age: 18 - 70+

Code: NCT06292923

Phase2, Recruiting